XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 32 filers reported holding XILIO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $31,541 | – | 33,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,441,444 | $1,365,768 | 20.01% |
| Bain Capital Life Sciences Investors, LLC | 3,785,450 | $3,586,714 | 0.39% |
| Rock Springs Capital Management LP | 3,003,259 | $2,845,588 | 0.09% |
| SevenBridge Financial Group, LLC | 41,000 | $37,179 | 0.01% |
| Dunhill Financial, LLC | 10,274 | $9,735 | 0.01% |
| Pinnacle Financial Group, LLC / IL | 10,000 | $9,475 | 0.00% |
| XTX Topco Ltd | 33,289 | $31,541 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 71,081 | $67,349 | 0.00% |
| Avantax Planning Partners, Inc. | 25,000 | $23,688 | 0.00% |
| BlackRock Inc. | 66,418 | $62,931 | 0.00% |